Aspen Pharmacare (South Africa) Price Prediction

APN Stock   16,802  71.00  0.42%   
The value of RSI of Aspen Pharmacare's share price is below 30 at the present time. This suggests that the stock is becoming oversold or undervalued. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Aspen Pharmacare Holdings, making its price go up or down.

Oversold Vs Overbought

24

 
Oversold
 
Overbought
The successful prediction of Aspen Pharmacare's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Aspen Pharmacare and does not consider all of the tangible or intangible factors available from Aspen Pharmacare's fundamental data. We analyze noise-free headlines and recent hype associated with Aspen Pharmacare Holdings, which may create opportunities for some arbitrage if properly timed.
Using Aspen Pharmacare hype-based prediction, you can estimate the value of Aspen Pharmacare Holdings from the perspective of Aspen Pharmacare response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Aspen Pharmacare to buy its stock at a price that has no basis in reality. In that case, they are not buying Aspen because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Aspen Pharmacare after-hype prediction price

    
  ZAC 16731.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Aspen Pharmacare Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
14,72114,72318,404
Details

Aspen Pharmacare After-Hype Price Prediction Density Analysis

As far as predicting the price of Aspen Pharmacare at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Aspen Pharmacare or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Aspen Pharmacare, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Aspen Pharmacare Estimiated After-Hype Price Volatility

In the context of predicting Aspen Pharmacare's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Aspen Pharmacare's historical news coverage. Aspen Pharmacare's after-hype downside and upside margins for the prediction period are 16,729 and 16,733, respectively. We have considered Aspen Pharmacare's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
16,802
16,729
Downside
16,731
After-hype Price
16,733
Upside
Aspen Pharmacare is very steady at this time. Analysis and calculation of next after-hype price of Aspen Pharmacare Holdings is based on 3 months time horizon.

Aspen Pharmacare Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Aspen Pharmacare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Aspen Pharmacare backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Aspen Pharmacare, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.49 
1.92
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
16,802
16,731
0.00 
0.00  
Notes

Aspen Pharmacare Hype Timeline

Aspen Pharmacare Holdings is presently traded for 16,802on Johannesburg Exchange of South Africa. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Aspen is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.49%. %. The volatility of related hype on Aspen Pharmacare is about 0.0%, with the expected price after the next announcement by competition of 16,802. About 19.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.88. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aspen Pharmacare Holdings recorded earning per share (EPS) of 14.32. The entity last dividend was issued on the 21st of September 2022. The firm had 407:400 split on the 6th of October 2008. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days.
Check out Aspen Pharmacare Basic Forecasting Models to cross-verify your projections.

Aspen Pharmacare Related Hype Analysis

Having access to credible news sources related to Aspen Pharmacare's direct competition is more important than ever and may enhance your ability to predict Aspen Pharmacare's future price movements. Getting to know how Aspen Pharmacare's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Aspen Pharmacare may potentially react to the hype associated with one of its peers.

Aspen Pharmacare Additional Predictive Modules

Most predictive techniques to examine Aspen price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Aspen using various technical indicators. When you analyze Aspen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Aspen Pharmacare Predictive Indicators

The successful prediction of Aspen Pharmacare stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Aspen Pharmacare Holdings, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Aspen Pharmacare based on analysis of Aspen Pharmacare hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Aspen Pharmacare's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Aspen Pharmacare's related companies.

Story Coverage note for Aspen Pharmacare

The number of cover stories for Aspen Pharmacare depends on current market conditions and Aspen Pharmacare's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Aspen Pharmacare is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Aspen Pharmacare's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Aspen Pharmacare Short Properties

Aspen Pharmacare's future price predictability will typically decrease when Aspen Pharmacare's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Aspen Pharmacare Holdings often depends not only on the future outlook of the potential Aspen Pharmacare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Aspen Pharmacare's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding453 M
Cash And Short Term Investments6.2 B

Complementary Tools for Aspen Stock analysis

When running Aspen Pharmacare's price analysis, check to measure Aspen Pharmacare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspen Pharmacare is operating at the current time. Most of Aspen Pharmacare's value examination focuses on studying past and present price action to predict the probability of Aspen Pharmacare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspen Pharmacare's price. Additionally, you may evaluate how the addition of Aspen Pharmacare to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments